Related Experiment Video
Updated: Jul 10, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.8K
Paraneoplastic Dermatoses and Cutaneous Metastases.
1Department of Dermatology, Tulane University School of Medicine, 1430 Tulane Avenue #8036, New Orleans, LA 70112, USA.
Clinics in Geriatric Medicine
|November 24, 2023
Summary
Paraneoplastic syndromes manifest diverse skin conditions linked to internal cancers. Early recognition of these cutaneous signs, including metastases, aids in diagnosing underlying malignancies.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Paraneoplastic syndromes encompass a spectrum of skin manifestations associated with internal malignancies.
- The correlation between specific syndromes and tumor types varies, with some linked to multiple cancers.
- Cutaneous signs can also indicate underlying hematologic disorders.
Purpose of the Study:
- To review the various cutaneous presentations of paraneoplastic syndromes.
- To highlight skin manifestations suggestive of hematologic disorders.
- To discuss the common origins and histological features of cutaneous metastases.
Main Methods:
- Literature review of paraneoplastic syndromes and their cutaneous manifestations.
- Analysis of common skin presentations associated with internal malignancies and hematologic disorders.
- Review of histological findings in cutaneous metastases.
Main Results:
- Cutaneous metastases, frequently from breast and lung cancers, present as nodules, vascular lesions, or dermatitis.
- The typical histology of cutaneous metastasis involves dermal or subcutaneous nodules with epidermal sparing.
- Certain skin conditions strongly correlate with specific internal malignancies or hematologic disorders.
Conclusions:
- Cutaneous manifestations are crucial indicators of underlying internal malignancies and hematologic disorders.
- Histopathological examination and clinical correlation are essential for determining the origin of cutaneous tumors.
- Prompt dermatological evaluation can facilitate early cancer diagnosis.
Related Concept Videos
Skin Diseases and Disorders
3.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.9K
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530

